Skip Navigation

Cardiovascular Research 2002 53(2):363-371; doi:10.1016/S0008-6363(01)00468-0
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zolk, O.
Right arrow Articles by Böhm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zolk, O.
Right arrow Articles by Böhm, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats

Oliver Zolka,*, Jessika Quattekb, Ute Seelandb, Ali El-Armouchea, Thomas Eschenhagena and Michael Böhmb

aInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstr. 17, 91054 Erlangen, Germany
bMedizinische Universitätsklinik und Poliklinik der Universität des Saarlandes, Innere Medizin — Kardiologie und Angiologie, 66421 Homburg, Germany

* Corresponding author. Tel.: +49-131-852-2783 zolk{at}pharmakologie.uni-erlangen.de

Objective: To characterize the cardiac angiotensin and endothelin (ET) system in compensated left ventricular hypertrophy due to long standing arterial hypertension and to assess the role of angiotensin and ET converting enzymes in mediating the observed changes of angiotensin and ET levels, respectively. Methods: We studied the left ventricular renin–angiotensin system (RAS) and ET system in 20-week-old male transgenic hypertensive TG(mREN2)27 rats, a model of the monogenic renin-dependent form of severe hypertension. Age-matched Sprague–Dawley rats served as controls. Results: TG(mREN2)27 rats exhibited left ventricular hypertrophy without signs of congestion. Transgene overexpression led to an activation of the tissue RAS with increased angiotensin II levels in spite of unchanged angiotensin converting enzyme (ACE) activity and ACE mRNA levels. ET-1 production was markedly increased in TG(mREN2)27 rats indicating that the ET-system was activated. Cardiac ET-1 in TG(mREN2)27 originated most likely from increased preproET-1 production because preproET-1 mRNA levels were increased but ET converting enzyme gene expression and activity were unchanged. Furthermore, ET-1 binding sites were significantly increased in TG(mREN2)27 rats without changes in KD values and ETA/ETB receptor ratios. ETA receptor gene expression was not altered whereas ETB receptor mRNA levels were up-regulated twofold in TG(mREN2)27 rats suggesting that ETA and ETB receptor expression may be regulated differentially. Conclusions: Cardiac ET and angiotensin systems are co-activated in compensated cardiac hypertrophy before onset of heart failure, and thus may be involved in the mechanism by which cardiac remodelling and progression of left ventricular dysfunction occur in TG(mREN2)27 rats.

KEYWORDS Endothelins; Hypertension; Hypertrophy; Renin angiotensin system


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Munzel, U. Muhlhauser, W.-H. Zimmermann, M. Didie, K. Schneiderbanger, P. Schubert, S. Engmann, T. Eschenhagen, and O. Zolk
Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition
Cardiovasc Res, December 1, 2005; 68(3): 464 - 474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. Zolk, F. Munzel, and T. Eschenhagen
Effects of chronic endothelin-1 stimulation on cardiac myocyte contractile function
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1248 - H1257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Motte, R. van Beneden, J. Mottet, B. Rondelet, M. Mathieu, X. Havaux, P. Lause, C. Clercx, J.-M. Ketelslegers, R. Naeije, et al.
Early activation of cardiac and renal endothelin systems in experimental heart failure
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2482 - H2491.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. E Cingolani, N. G Perez, B. Pieske, D. von Lewinski, and M. C Camilion de Hurtado
Stretch-elicited Na+/H+ exchanger activation: the autocrine/paracrine loop and its mechanical counterpart
Cardiovasc Res, March 15, 2003; 57(4): 953 - 960.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. P. Rossi, M. Cavallin, A. S Belloni, G. Mazzocchi, G. G Nussdorfer, A. C Pessina, and S. Sartore
Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension
Cardiovasc Res, July 1, 2002; 55(1): 178 - 189.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.